Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms

MYPI2025005270A0Undetermined Publication Date: 2014-06-07GERON CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025005270
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2013-11-05
Filing Date
2013-11-15
Publication Date
2014-06-07
Patent Text Reader

Abstract

Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have myeloproliferative disorders, such as Essential Thrombocythemia (ET). Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having myeloproliferative disorder s, such as ET. Fig. 1
Need to check novelty before this filing date? Find Prior Art